Laser toning for melasma

Melasma is often spoken about as if it were pigment sitting politely on the surface, waiting for the right laser to clear it away. That is not how melasma behaves.

It is a chronic pigment disorder influenced by light, hormones, heat, inflammation, blood vessels, and the skin’s own signaling. It can fade beautifully and return after a sunny afternoon. Which is why a treatment called “laser toning” can be both genuinely useful and easy to overpromise.

In the melasma literature, laser toning usually refers to repeated passes of a low-fluence, 1064-nanometer Q-switched Nd:YAG laser. Low fluence means each pulse carries relatively modest energy. The intention is to disrupt excess melanin gradually while limiting the inflammation that can tell pigment-producing cells to make even more.

The gentleness is cumulative. Protocols commonly involve a series rather than one heroic appointment, and the skin may look brighter with little downtime along the way. This rhythm helped make toning a fixture in Asian dermatology clinics.

It also creates the central temptation: if a little works, keep going.

A systematic review of 42 studies found low-fluence laser toning generally effective, but documented persistent mottled hypopigmentation in some patients, particularly with high accumulated energy. Aggressive treatment can also trigger inflammation and rebound hyperpigmentation, especially in deeper skin tones.

A separate meta-analysis covering 1,772 patients found that the benefit of laser toning alone diminished over time. Hypopigmentation or leukoderma correlated with the number of sessions. The lesson is uncomfortable but clear: repeated low energy is not the same thing as unlimited safety.

And melasma returns. A 2026 review of randomized trials found that low-fluence Q-switched Nd:YAG produced a modest reduction in severity, but the evidence was highly inconsistent and overall certainty was very low. Its authors placed laser as an adjunct to strict photoprotection and topical pigment control, not a solo cure.

A sensible melasma plan usually begins with the less glamorous work: daily broad-spectrum sunscreen, visible-light protection when appropriate, heat awareness, and topical treatment selected by a clinician. Hydroquinone, azelaic acid, retinoids, cysteamine, and tranexamic acid may enter the conversation depending on the person; each has its own risks and contraindications.

Only then does a device make sense. The provider needs to distinguish melasma from sun spots and post-inflammatory pigment, because the same dark patch can require a very different strategy. They also need to watch the response across a course and know when improvement has plateaued. Maintenance does not have to mean another laser forever.

This is also where “pico” and “toning” get blurred. Picosecond lasers use shorter pulses, while classic laser toning research centers on Q-switched nanosecond technology. Both may be used at low fluence for pigment. Neither pulse duration removes melasma’s tendency to react and recur.

Laser toning can clear some of the haze. It cannot change the fact that melasma has a memory. The best result comes from treating that biology with restraint, then protecting the improvement long after the laser is off.